nodes	percent_of_prediction	percent_of_DWPC	metapath
Gallamine Triethiodide—Odynophagia—Docetaxel—melanoma	0.043	0.0531	CcSEcCtD
Gallamine Triethiodide—Infertility—Carmustine—melanoma	0.0321	0.0397	CcSEcCtD
Gallamine Triethiodide—Infertility—Temozolomide—melanoma	0.031	0.0383	CcSEcCtD
Gallamine Triethiodide—Polyp—Vemurafenib—melanoma	0.0261	0.0322	CcSEcCtD
Gallamine Triethiodide—Cyst—Vemurafenib—melanoma	0.0237	0.0293	CcSEcCtD
Gallamine Triethiodide—Neoplasm malignant—Vemurafenib—melanoma	0.0186	0.0229	CcSEcCtD
Gallamine Triethiodide—Eruption—Dactinomycin—melanoma	0.0146	0.018	CcSEcCtD
Gallamine Triethiodide—Neoplasm—Vemurafenib—melanoma	0.0143	0.0177	CcSEcCtD
Gallamine Triethiodide—Cyst—Carmustine—melanoma	0.0125	0.0155	CcSEcCtD
Gallamine Triethiodide—Tenderness—Bleomycin—melanoma	0.011	0.0136	CcSEcCtD
Gallamine Triethiodide—Eosinophilia—Vemurafenib—melanoma	0.00985	0.0122	CcSEcCtD
Gallamine Triethiodide—Endocrine disorder—Temozolomide—melanoma	0.00977	0.0121	CcSEcCtD
Gallamine Triethiodide—Polyp—Docetaxel—melanoma	0.00885	0.0109	CcSEcCtD
Gallamine Triethiodide—Eruption—Docetaxel—melanoma	0.00876	0.0108	CcSEcCtD
Gallamine Triethiodide—Cyst—Docetaxel—melanoma	0.00806	0.00995	CcSEcCtD
Gallamine Triethiodide—Neoplasm—Carmustine—melanoma	0.00758	0.00936	CcSEcCtD
Gallamine Triethiodide—Throat sore—Docetaxel—melanoma	0.00747	0.00923	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Vemurafenib—melanoma	0.00744	0.00919	CcSEcCtD
Gallamine Triethiodide—Oropharyngeal discomfort—Docetaxel—melanoma	0.00741	0.00915	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Vemurafenib—melanoma	0.00739	0.00912	CcSEcCtD
Gallamine Triethiodide—Neoplasm—Temozolomide—melanoma	0.00732	0.00905	CcSEcCtD
Gallamine Triethiodide—Swelling—Carmustine—melanoma	0.0069	0.00852	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Vemurafenib—melanoma	0.00679	0.00838	CcSEcCtD
Gallamine Triethiodide—Eye irritation—Docetaxel—melanoma	0.00631	0.00779	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal haemorrhage—Carmustine—melanoma	0.00608	0.00752	CcSEcCtD
Gallamine Triethiodide—Cough—Vemurafenib—melanoma	0.00605	0.00747	CcSEcCtD
Gallamine Triethiodide—Oropharyngeal pain—Docetaxel—melanoma	0.00592	0.00732	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Vemurafenib—melanoma	0.0059	0.00729	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00586	0.00724	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Bleomycin—melanoma	0.00572	0.00707	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Vemurafenib—melanoma	0.00549	0.00678	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Dactinomycin—melanoma	0.00534	0.00659	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00515	0.00636	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Carmustine—melanoma	0.00499	0.00617	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Vemurafenib—melanoma	0.00488	0.00603	CcSEcCtD
Gallamine Triethiodide—Fatigue—Vemurafenib—melanoma	0.00488	0.00602	CcSEcCtD
Gallamine Triethiodide—Neoplasm—Docetaxel—melanoma	0.00487	0.00602	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Bleomycin—melanoma	0.00485	0.00599	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Temozolomide—melanoma	0.00483	0.00596	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Bleomycin—melanoma	0.00482	0.00596	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Bleomycin—melanoma	0.0048	0.00593	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Vemurafenib—melanoma	0.00447	0.00552	CcSEcCtD
Gallamine Triethiodide—Swelling—Docetaxel—melanoma	0.00443	0.00547	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Carmustine—melanoma	0.00423	0.00523	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Carmustine—melanoma	0.00421	0.0052	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Carmustine—melanoma	0.00419	0.00517	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Vemurafenib—melanoma	0.00417	0.00515	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Temozolomide—melanoma	0.00409	0.00505	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Temozolomide—melanoma	0.00407	0.00502	CcSEcCtD
Gallamine Triethiodide—Asthenia—Vemurafenib—melanoma	0.00406	0.00501	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Temozolomide—melanoma	0.00405	0.005	CcSEcCtD
Gallamine Triethiodide—Pruritus—Vemurafenib—melanoma	0.004	0.00494	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Carmustine—melanoma	0.00393	0.00486	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.00391	0.00483	CcSEcCtD
Gallamine Triethiodide—Anaemia—Bleomycin—melanoma	0.00388	0.00479	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Vemurafenib—melanoma	0.00387	0.00478	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Temozolomide—melanoma	0.0038	0.0047	CcSEcCtD
Gallamine Triethiodide—Malaise—Bleomycin—melanoma	0.00379	0.00468	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Temozolomide—melanoma	0.00378	0.00466	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Bleomycin—melanoma	0.00376	0.00464	CcSEcCtD
Gallamine Triethiodide—Cough—Bleomycin—melanoma	0.00366	0.00452	CcSEcCtD
Gallamine Triethiodide—Anaemia—Dactinomycin—melanoma	0.00362	0.00447	CcSEcCtD
Gallamine Triethiodide—Vomiting—Vemurafenib—melanoma	0.0036	0.00444	CcSEcCtD
Gallamine Triethiodide—Chest pain—Bleomycin—melanoma	0.00357	0.00441	CcSEcCtD
Gallamine Triethiodide—Abdominal pain upper—Docetaxel—melanoma	0.00357	0.00441	CcSEcCtD
Gallamine Triethiodide—Rash—Vemurafenib—melanoma	0.00357	0.0044	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Vemurafenib—melanoma	0.00356	0.0044	CcSEcCtD
Gallamine Triethiodide—Headache—Vemurafenib—melanoma	0.00354	0.00438	CcSEcCtD
Gallamine Triethiodide—Malaise—Dactinomycin—melanoma	0.00353	0.00436	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Dactinomycin—melanoma	0.0035	0.00433	CcSEcCtD
Gallamine Triethiodide—Nasopharyngitis—Docetaxel—melanoma	0.0035	0.00432	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Temozolomide—melanoma	0.00347	0.00428	CcSEcCtD
Gallamine Triethiodide—Confusional state—Bleomycin—melanoma	0.00345	0.00427	CcSEcCtD
Gallamine Triethiodide—Anaemia—Carmustine—melanoma	0.00339	0.00418	CcSEcCtD
Gallamine Triethiodide—Nausea—Vemurafenib—melanoma	0.00336	0.00415	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Bleomycin—melanoma	0.00335	0.00414	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Carmustine—melanoma	0.00328	0.00405	CcSEcCtD
Gallamine Triethiodide—Anaemia—Temozolomide—melanoma	0.00327	0.00404	CcSEcCtD
Gallamine Triethiodide—Angioedema—Temozolomide—melanoma	0.00324	0.004	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Docetaxel—melanoma	0.00321	0.00396	CcSEcCtD
Gallamine Triethiodide—Malaise—Temozolomide—melanoma	0.00319	0.00394	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Temozolomide—melanoma	0.00317	0.00392	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Dactinomycin—melanoma	0.00313	0.00386	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Bleomycin—melanoma	0.00312	0.00386	CcSEcCtD
Gallamine Triethiodide—Chest pain—Carmustine—melanoma	0.00312	0.00385	CcSEcCtD
Gallamine Triethiodide—Cough—Temozolomide—melanoma	0.00309	0.00382	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Bleomycin—melanoma	0.00308	0.0038	CcSEcCtD
Gallamine Triethiodide—Confusional state—Carmustine—melanoma	0.00302	0.00372	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Temozolomide—melanoma	0.00301	0.00372	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00299	0.0037	CcSEcCtD
Gallamine Triethiodide—Pain—Bleomycin—melanoma	0.00293	0.00362	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Carmustine—melanoma	0.00293	0.00362	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Carmustine—melanoma	0.00292	0.00361	CcSEcCtD
Gallamine Triethiodide—Confusional state—Temozolomide—melanoma	0.00291	0.0036	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00291	0.0036	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Temozolomide—melanoma	0.00283	0.00349	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Bleomycin—melanoma	0.00282	0.00349	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Temozolomide—melanoma	0.00281	0.00347	CcSEcCtD
Gallamine Triethiodide—Fatigue—Dactinomycin—melanoma	0.00275	0.0034	CcSEcCtD
Gallamine Triethiodide—Pain—Dactinomycin—melanoma	0.00273	0.00337	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Carmustine—melanoma	0.00272	0.00337	CcSEcCtD
Gallamine Triethiodide—Urticaria—Bleomycin—melanoma	0.00272	0.00336	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Docetaxel—melanoma	0.00272	0.00336	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Docetaxel—melanoma	0.00271	0.00335	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Bleomycin—melanoma	0.00271	0.00335	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Docetaxel—melanoma	0.00271	0.00334	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Docetaxel—melanoma	0.00269	0.00332	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Carmustine—melanoma	0.00269	0.00332	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Dactinomycin—melanoma	0.00263	0.00325	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Temozolomide—melanoma	0.00263	0.00325	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Temozolomide—melanoma	0.0026	0.00321	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Carmustine—melanoma	0.00258	0.00319	CcSEcCtD
Gallamine Triethiodide—Pain—Carmustine—melanoma	0.00256	0.00316	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Docetaxel—melanoma	0.00253	0.00312	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Dactinomycin—melanoma	0.00253	0.00312	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Dactinomycin—melanoma	0.00253	0.00312	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Bleomycin—melanoma	0.00252	0.00312	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Docetaxel—melanoma	0.00251	0.0031	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Temozolomide—melanoma	0.0025	0.00308	CcSEcCtD
Gallamine Triethiodide—Fatigue—Temozolomide—melanoma	0.00249	0.00308	CcSEcCtD
Gallamine Triethiodide—Pain—Temozolomide—melanoma	0.00247	0.00305	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Carmustine—melanoma	0.00246	0.00304	CcSEcCtD
Gallamine Triethiodide—Asthenia—Bleomycin—melanoma	0.00246	0.00304	CcSEcCtD
Gallamine Triethiodide—Pruritus—Bleomycin—melanoma	0.00242	0.00299	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Temozolomide—melanoma	0.00238	0.00294	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Carmustine—melanoma	0.00236	0.00292	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Carmustine—melanoma	0.00236	0.00292	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Dactinomycin—melanoma	0.00235	0.00291	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Docetaxel—melanoma	0.00231	0.00285	CcSEcCtD
Gallamine Triethiodide—Urticaria—Temozolomide—melanoma	0.0023	0.00284	CcSEcCtD
Gallamine Triethiodide—Asthenia—Dactinomycin—melanoma	0.00229	0.00283	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Temozolomide—melanoma	0.00228	0.00282	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Temozolomide—melanoma	0.00228	0.00282	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Carmustine—melanoma	0.0022	0.00272	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Dactinomycin—melanoma	0.00219	0.0027	CcSEcCtD
Gallamine Triethiodide—Vomiting—Bleomycin—melanoma	0.00218	0.00269	CcSEcCtD
Gallamine Triethiodide—Anaemia—Docetaxel—melanoma	0.00218	0.00269	CcSEcCtD
Gallamine Triethiodide—Rash—Bleomycin—melanoma	0.00216	0.00267	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Bleomycin—melanoma	0.00216	0.00267	CcSEcCtD
Gallamine Triethiodide—Asthenia—Carmustine—melanoma	0.00215	0.00265	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Temozolomide—melanoma	0.00213	0.00263	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Docetaxel—melanoma	0.00211	0.0026	CcSEcCtD
Gallamine Triethiodide—Asthenia—Temozolomide—melanoma	0.00207	0.00256	CcSEcCtD
Gallamine Triethiodide—Cough—Docetaxel—melanoma	0.00205	0.00254	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Carmustine—melanoma	0.00205	0.00253	CcSEcCtD
Gallamine Triethiodide—Pruritus—Temozolomide—melanoma	0.00204	0.00253	CcSEcCtD
Gallamine Triethiodide—Nausea—Bleomycin—melanoma	0.00204	0.00251	CcSEcCtD
Gallamine Triethiodide—Vomiting—Dactinomycin—melanoma	0.00203	0.00251	CcSEcCtD
Gallamine Triethiodide—Rash—Dactinomycin—melanoma	0.00201	0.00249	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Docetaxel—melanoma	0.002	0.00248	CcSEcCtD
Gallamine Triethiodide—Chest pain—Docetaxel—melanoma	0.002	0.00248	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00199	0.00246	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Temozolomide—melanoma	0.00198	0.00244	CcSEcCtD
Gallamine Triethiodide—Confusional state—Docetaxel—melanoma	0.00194	0.00239	CcSEcCtD
Gallamine Triethiodide—Vomiting—Carmustine—melanoma	0.0019	0.00235	CcSEcCtD
Gallamine Triethiodide—Nausea—Dactinomycin—melanoma	0.0019	0.00234	CcSEcCtD
Gallamine Triethiodide—Rash—Carmustine—melanoma	0.00189	0.00233	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Carmustine—melanoma	0.00188	0.00233	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Docetaxel—melanoma	0.00188	0.00232	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Docetaxel—melanoma	0.00188	0.00232	CcSEcCtD
Gallamine Triethiodide—Headache—Carmustine—melanoma	0.00187	0.00231	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Docetaxel—melanoma	0.00187	0.00231	CcSEcCtD
Gallamine Triethiodide—Vomiting—Temozolomide—melanoma	0.00184	0.00227	CcSEcCtD
Gallamine Triethiodide—Rash—Temozolomide—melanoma	0.00182	0.00225	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Temozolomide—melanoma	0.00182	0.00225	CcSEcCtD
Gallamine Triethiodide—Headache—Temozolomide—melanoma	0.00181	0.00224	CcSEcCtD
Gallamine Triethiodide—Nausea—Carmustine—melanoma	0.00178	0.00219	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Docetaxel—melanoma	0.00175	0.00216	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Docetaxel—melanoma	0.00173	0.00213	CcSEcCtD
Gallamine Triethiodide—Nausea—Temozolomide—melanoma	0.00172	0.00212	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Docetaxel—melanoma	0.00166	0.00205	CcSEcCtD
Gallamine Triethiodide—Fatigue—Docetaxel—melanoma	0.00166	0.00205	CcSEcCtD
Gallamine Triethiodide—Pain—Docetaxel—melanoma	0.00164	0.00203	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Docetaxel—melanoma	0.00158	0.00196	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Docetaxel—melanoma	0.00152	0.00188	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Docetaxel—melanoma	0.00152	0.00188	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Docetaxel—melanoma	0.00142	0.00175	CcSEcCtD
Gallamine Triethiodide—Asthenia—Docetaxel—melanoma	0.00138	0.0017	CcSEcCtD
Gallamine Triethiodide—Pruritus—Docetaxel—melanoma	0.00136	0.00168	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Docetaxel—melanoma	0.00131	0.00162	CcSEcCtD
Gallamine Triethiodide—Vomiting—Docetaxel—melanoma	0.00122	0.00151	CcSEcCtD
Gallamine Triethiodide—Rash—Docetaxel—melanoma	0.00121	0.0015	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Docetaxel—melanoma	0.00121	0.0015	CcSEcCtD
Gallamine Triethiodide—Headache—Docetaxel—melanoma	0.0012	0.00149	CcSEcCtD
Gallamine Triethiodide—Nausea—Docetaxel—melanoma	0.00114	0.00141	CcSEcCtD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	0.000296	0.00156	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—HSPA5—melanoma	0.000294	0.00154	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—FGF2—melanoma	0.000294	0.00154	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—EDNRB—melanoma	0.000294	0.00154	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—BRAF—melanoma	0.000292	0.00154	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MYO7A—melanoma	0.000292	0.00153	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—DRAP1—melanoma	0.000292	0.00153	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	0.000289	0.00152	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	0.000286	0.0015	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Transmission across Chemical Synapses—HRAS—melanoma	0.000284	0.00149	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GRM3—melanoma	0.000281	0.00147	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	0.00028	0.00147	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	0.000279	0.00147	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	0.000278	0.00146	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—F2RL1—melanoma	0.000271	0.00142	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Neuronal System—MAPK1—melanoma	0.000271	0.00142	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PHGDH—melanoma	0.00027	0.00142	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—LUM—melanoma	0.00027	0.00142	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—PIK3CB—melanoma	0.000267	0.0014	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—KISS1—melanoma	0.000266	0.0014	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—HPSE—melanoma	0.000265	0.00139	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—melanoma	0.000263	0.00138	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CXCR4—melanoma	0.000261	0.00137	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CUBN—melanoma	0.00026	0.00137	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CXCR1—melanoma	0.000258	0.00135	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Phospholipid metabolism—PIK3CA—melanoma	0.000255	0.00134	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GRM3—melanoma	0.000255	0.00134	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—MC1R—melanoma	0.000254	0.00133	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	0.000252	0.00132	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—SDHD—melanoma	0.000251	0.00132	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CSPG4—melanoma	0.000251	0.00132	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—BSG—melanoma	0.000251	0.00132	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TAS2R60—melanoma	0.000248	0.00131	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—CXCL8—melanoma	0.000248	0.0013	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—MDM2—melanoma	0.000245	0.00129	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GPAM—melanoma	0.000243	0.00128	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GRM1—melanoma	0.000243	0.00128	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CCR7—melanoma	0.000243	0.00128	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—KISS1—melanoma	0.000242	0.00127	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	0.000238	0.00125	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—CASP3—melanoma	0.000237	0.00125	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CXCR1—melanoma	0.000234	0.00123	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—MYC—melanoma	0.000232	0.00122	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—MC1R—melanoma	0.00023	0.00121	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—CTNNB1—melanoma	0.000229	0.0012	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	0.000227	0.00119	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	0.000227	0.00119	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—NFKB1—melanoma	0.000222	0.00116	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—RHOB—melanoma	0.000221	0.00116	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GRM1—melanoma	0.000221	0.00116	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CCR7—melanoma	0.000221	0.00116	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Transmission across Chemical Synapses—MAPK1—melanoma	0.000219	0.00115	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Neuronal System—HRAS—melanoma	0.000217	0.00114	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—TNF—melanoma	0.000216	0.00113	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	0.000214	0.00112	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PLA2G6—melanoma	0.000207	0.00109	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—NRAS—melanoma	0.000206	0.00108	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CXCR2—melanoma	0.000202	0.00106	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—VEGFA—melanoma	0.000201	0.00106	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—RHOB—melanoma	0.000201	0.00106	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—EDN1—melanoma	0.0002	0.00105	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—RAC2—melanoma	0.000198	0.00104	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—MAPK3—melanoma	0.000197	0.00104	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	0.000197	0.00103	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—TP53—melanoma	0.00019	0.001	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PLCB4—melanoma	0.000188	0.000989	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CXCL1—melanoma	0.000188	0.000989	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—MAPK1—melanoma	0.000188	0.000987	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—EGFR—melanoma	0.000188	0.000987	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—VCAN—melanoma	0.000186	0.000976	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CXCR2—melanoma	0.000183	0.000962	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—RAC2—melanoma	0.00018	0.000946	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—CXCL8—melanoma	0.000179	0.000938	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—KRAS—melanoma	0.000177	0.000932	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—WNT5A—melanoma	0.000177	0.000931	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TRRAP—melanoma	0.000177	0.00093	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CUL3—melanoma	0.000177	0.00093	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	0.000176	0.000924	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Transmission across Chemical Synapses—HRAS—melanoma	0.000175	0.000922	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—MMP1—melanoma	0.000174	0.000914	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—TNF—melanoma	0.000172	0.000906	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AKR1B10—melanoma	0.000172	0.000905	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—F2R—melanoma	0.000171	0.0009	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PPARG—melanoma	0.00017	0.000892	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—MAPK1—melanoma	0.000167	0.00088	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—EDNRB—melanoma	0.000166	0.000872	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—melanoma	0.000163	0.000856	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	0.000161	0.000844	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—F2RL1—melanoma	0.00016	0.000841	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP17A1—melanoma	0.000157	0.000824	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GAB2—melanoma	0.000157	0.000824	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GNA11—melanoma	0.000157	0.000824	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—F2R—melanoma	0.000156	0.000818	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	0.000155	0.000812	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—ALB—melanoma	0.000153	0.000802	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—EDNRB—melanoma	0.000151	0.000792	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GRM3—melanoma	0.000151	0.000791	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GNA11—melanoma	0.000148	0.000778	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CXCR4—melanoma	0.000147	0.000774	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GNAQ—melanoma	0.000146	0.000766	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—FASN—melanoma	0.000145	0.000761	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—KISS1—melanoma	0.000143	0.00075	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—SLC5A5—melanoma	0.000143	0.000749	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GAB2—melanoma	0.000142	0.000748	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GNA11—melanoma	0.000142	0.000748	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—melanoma	0.000142	0.000746	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—IL6—melanoma	0.000139	0.000731	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—IGF1—melanoma	0.000139	0.000731	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SKI—melanoma	0.000138	0.000726	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CXCR1—melanoma	0.000138	0.000726	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GNAQ—melanoma	0.000138	0.000723	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CD44—melanoma	0.000138	0.000723	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MC1R—melanoma	0.000136	0.000715	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	0.000135	0.000708	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—MMP2—melanoma	0.000135	0.000707	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—AKT3—melanoma	0.000135	0.000707	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—HRAS—melanoma	0.000134	0.000706	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CXCR4—melanoma	0.000134	0.000703	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PTGS2—melanoma	0.000134	0.000701	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GNAQ—melanoma	0.000132	0.000695	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP1B1—melanoma	0.000132	0.000693	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GRM1—melanoma	0.000131	0.000686	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCR7—melanoma	0.000131	0.000686	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SUFU—melanoma	0.000127	0.000668	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—AKT3—melanoma	0.000122	0.000642	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—RHOB—melanoma	0.000119	0.000624	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—BCL2L11—melanoma	0.000119	0.000624	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PTEN—melanoma	0.000116	0.000612	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HDAC6—melanoma	0.000114	0.000599	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—EDN1—melanoma	0.000113	0.000594	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—CXCL8—melanoma	0.000112	0.000588	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CSF2—melanoma	0.00011	0.00058	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ABCB1—melanoma	0.000109	0.000571	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CXCR2—melanoma	0.000108	0.000568	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CXCL8—melanoma	0.000108	0.000568	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—RAC2—melanoma	0.000106	0.000559	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PRKCA—melanoma	0.000106	0.000556	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—VEGFC—melanoma	0.000105	0.00055	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—WNT5A—melanoma	0.000105	0.00055	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—CTNNB1—melanoma	0.000103	0.000542	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—EDN1—melanoma	0.000103	0.000539	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CSF2—melanoma	0.0001	0.000527	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PRKCA—melanoma	0.0001	0.000525	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ERCC2—melanoma	9.92e-05	0.000521	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—RAC1—melanoma	9.82e-05	0.000516	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PRKCA—melanoma	9.62e-05	0.000505	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—MAP2K2—melanoma	9.4e-05	0.000494	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—F2R—melanoma	9.2e-05	0.000483	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—RAC1—melanoma	8.92e-05	0.000468	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—EDNRB—melanoma	8.91e-05	0.000468	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PTK2B—melanoma	8.65e-05	0.000454	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GAB2—melanoma	8.41e-05	0.000442	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GNA11—melanoma	8.41e-05	0.000442	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FLT1—melanoma	8.37e-05	0.00044	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PIK3CG—melanoma	8.29e-05	0.000436	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	8.22e-05	0.000432	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CXCR4—melanoma	7.91e-05	0.000415	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FOXO4—melanoma	7.91e-05	0.000415	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HDAC2—melanoma	7.91e-05	0.000415	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PIK3CG—melanoma	7.83e-05	0.000411	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GNAQ—melanoma	7.82e-05	0.000411	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PPARG—melanoma	7.56e-05	0.000397	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PIK3CG—melanoma	7.53e-05	0.000396	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SYK—melanoma	7.35e-05	0.000386	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PIK3CD—melanoma	7.29e-05	0.000383	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AKT3—melanoma	7.22e-05	0.000379	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ITGAV—melanoma	7.22e-05	0.000379	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NGFR—melanoma	7.22e-05	0.000379	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PIK3CD—melanoma	6.89e-05	0.000362	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ALB—melanoma	6.8e-05	0.000357	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SOCS1—melanoma	6.68e-05	0.000351	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—MAP2K1—melanoma	6.67e-05	0.00035	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—S100B—melanoma	6.66e-05	0.00035	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PIK3CD—melanoma	6.62e-05	0.000348	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ERBB4—melanoma	6.37e-05	0.000335	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PIK3CB—melanoma	6.36e-05	0.000334	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CDKN2B—melanoma	6.32e-05	0.000332	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CD86—melanoma	6.11e-05	0.000321	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CXCL8—melanoma	6.11e-05	0.000321	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—EDN1—melanoma	6.06e-05	0.000318	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PIK3CB—melanoma	6e-05	0.000315	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PTGS2—melanoma	5.95e-05	0.000312	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CSF2—melanoma	5.93e-05	0.000311	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FGF1—melanoma	5.93e-05	0.000311	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—IL2—melanoma	5.84e-05	0.000307	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—E2F1—melanoma	5.8e-05	0.000305	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PIK3CB—melanoma	5.77e-05	0.000303	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PDGFRA—melanoma	5.74e-05	0.000301	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PRKCA—melanoma	5.68e-05	0.000298	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ITGB3—melanoma	5.68e-05	0.000298	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SPP1—melanoma	5.57e-05	0.000293	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MAP2K2—melanoma	5.55e-05	0.000292	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CXCL8—melanoma	5.55e-05	0.000291	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—IL2—melanoma	5.3e-05	0.000278	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TERT—melanoma	5.28e-05	0.000277	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—RAC1—melanoma	5.27e-05	0.000277	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PTEN—melanoma	5.19e-05	0.000272	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HIF1A—melanoma	5.05e-05	0.000265	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—KDR—melanoma	4.83e-05	0.000254	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FN1—melanoma	4.65e-05	0.000244	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NOTCH1—melanoma	4.55e-05	0.000239	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CD80—melanoma	4.46e-05	0.000234	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—KIT—melanoma	4.45e-05	0.000234	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—APC—melanoma	4.45e-05	0.000234	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PIK3CG—melanoma	4.45e-05	0.000234	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—NRAS—melanoma	4.45e-05	0.000234	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—EGF—melanoma	4.4e-05	0.000231	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—MAPK3—melanoma	4.26e-05	0.000224	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—BRAF—melanoma	4.18e-05	0.00022	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IGF1—melanoma	4.07e-05	0.000214	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—MAPK1—melanoma	4.05e-05	0.000213	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—EGFR—melanoma	4.05e-05	0.000213	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MAP2K1—melanoma	3.94e-05	0.000207	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PIK3CD—melanoma	3.91e-05	0.000205	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PIK3CA—melanoma	3.87e-05	0.000204	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—KRAS—melanoma	3.83e-05	0.000201	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FGF2—melanoma	3.75e-05	0.000197	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PIK3CA—melanoma	3.66e-05	0.000192	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PIK3CA—melanoma	3.52e-05	0.000185	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MDM2—melanoma	3.5e-05	0.000184	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ERBB2—melanoma	3.45e-05	0.000181	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PIK3CB—melanoma	3.41e-05	0.000179	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CXCL8—melanoma	3.28e-05	0.000172	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—HRAS—melanoma	3.26e-05	0.000171	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CDKN1B—melanoma	3.2e-05	0.000168	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—AKT1—melanoma	3.17e-05	0.000166	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CASP3—melanoma	3.14e-05	0.000165	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IL2—melanoma	3.13e-05	0.000164	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—IL6—melanoma	3.12e-05	0.000164	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCND1—melanoma	3.05e-05	0.00016	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CTNNB1—melanoma	3.02e-05	0.000159	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—AKT1—melanoma	2.99e-05	0.000157	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MMP9—melanoma	2.96e-05	0.000156	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CDKN1A—melanoma	2.95e-05	0.000155	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PTEN—melanoma	2.95e-05	0.000155	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NFKB1—melanoma	2.93e-05	0.000154	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—AKT1—melanoma	2.87e-05	0.000151	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—VEGFA—melanoma	2.66e-05	0.00014	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—STAT3—melanoma	2.63e-05	0.000138	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NRAS—melanoma	2.63e-05	0.000138	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MAPK3—melanoma	2.52e-05	0.000132	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MYC—melanoma	2.45e-05	0.000129	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MAPK1—melanoma	2.4e-05	0.000126	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—EGFR—melanoma	2.39e-05	0.000126	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—KRAS—melanoma	2.26e-05	0.000119	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PIK3CA—melanoma	2.08e-05	0.000109	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TP53—melanoma	2.01e-05	0.000106	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HRAS—melanoma	1.92e-05	0.000101	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IL6—melanoma	1.84e-05	9.67e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AKT1—melanoma	1.7e-05	8.92e-05	CbGpPWpGaD
